Overexpression of Hepatocyte Chemerin-156 Lowers Tumor Burden in a Murine Model of Diethylnitrosamine-Induced Hepatocellular Carcinoma

URN to cite this document:: urn:nbn:de:bvb:355-epub-415028
DOI to cite this document:: 10.5283/epub.41502

Haberl, Elisabeth M. ; Pohl, Rebekka ; Rein-Fischboeck, Lisa ; Feder, Susanne ; Bruckmann, Astrid ; Höring, Marcus ; Krautbauer, Sabrina ; Liebisch, Gerhard ; Buechler, Christa ; ,

Preview

License: Creative Commons Attribution 4.0
PDF - Published Version
(2MB)

Date of publication of this fulltext: 05 Feb 2020 14:50

Alternative links to fulltext:DOI Publisher

Details

Preview

Indexed in

Export bibliographical data

Abstract

The tumor inhibitory potential of the highly active chemerin-156 isoform was described in orthotopic models of hepatocellular carcinoma (HCC). The majority of HCC arises in the fibrotic liver, which was not reproduced in these studies. Here, a potential therapeutic activity of chemerin-156 was evaluated in diethylnitrosamine (DEN)-induced liver cancer, which mimics fibrosis-associated HCC. Mice ...